Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - SOLIGENIX, INC. | Financial_Report.xls |
| 10-K - ANNUAL REPORT - SOLIGENIX, INC. | f10k2014_soligenixinc.htm |
| EX-32.1 - CERTIFICATION - SOLIGENIX, INC. | f10k2014ex32i_soligenix.htm |
| EX-31.1 - CERTIFICATION - SOLIGENIX, INC. | f10k2014ex31i_soligenix.htm |
| EX-32.2 - CERTIFICATION - SOLIGENIX, INC. | f10k2014ex32ii_soligenix.htm |
| EX-31.2 - CERTIFICATION - SOLIGENIX, INC. | f10k2014ex31ii_soligenix.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - SOLIGENIX, INC. | f10k2014ex23i_soligenixinc.htm |
| EX-10.42 - LEASE AGREEMENT - SOLIGENIX, INC. | f10k2014ex10xlii_soligenix.htm |
EXHIBIT 21.1
SUBSIDIARIES OF SOLIGENIX, INC.
The following represents a list of Soligenix, Inc.’s subsidiaries:
| Name | Ownership | State of Incorporation | ||||
| Enteron Pharmaceuticals, Inc. | 100.00 | % | Delaware | |||
| Orasomal Technologies Inc. | 75.30 | % | Delaware | |||
| DOR BioDefense Corp. | 100.00 | % | Delaware | |||
| Soligenix BioPharma Canada Incorporated | 100.00 | % | Canada | |||
| Soligenix UK Limited | 100.00 | % | United Kingdom | |||